Example: marketing
Guideline - ESGE

Guideline - ESGE

Back to document page

1 Patients with chronic atrophic gastritis or intestinal metaplasia are at risk for gastric adenocarcinoma. High quality evidence (100% agree [94% strongly or moderately agree]). STATEMENT 2 Histologically confirmed intestinal metaplasia is the most reliable marker of atrophy in gastric mucosa. High quality evidence (100% agree [100% strongly or

  Intestinal, Metaplasia, Intestinal metaplasia

Download Guideline - ESGE


Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Related search queries